Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dexmedetomidine and Subarachnoid Haemorrhage

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by Turku University Hospital
Sponsor:
Collaborator:
Orion Corporation, Orion Pharma
Information provided by (Responsible Party):
Riikka Takala, Turku University Hospital
ClinicalTrials.gov Identifier:
NCT01664520
First received: August 4, 2012
Last updated: April 28, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)